projects
PSG923 „Deciphering the role of N6AMT1 in Tumorigenesis and other Pathologies“ (1.01.2024-31.12.2028);
Principal Investigator: Margit Mutso. Financier: Estonian Research Council. Financing: 584 998 EUR.
MLTTI24159 "Study towards understanding of oscillatory mechanisms of cell-fate change" (1.02.2024−31.10.2024);
Principal Investigator: Reet Kurg. Financier: Baltic-German University Liaison Office (Baltish-Deutsches Hochschulkontor); Financing: 4 721 EUR.
PLTTIARENG56 „Development of purification platform for plant-derived extracellular vesicles” (1.06.2023−31.05.2024); Principal Investigator: Reet Kurg. UT Experimental Development project. Financier: University of Tartu; Financing: 39 500 EUR.
PRG1506 "Design of Peptide-based Nanoparticles for Delivery of Therapeutic Oligonucleotides " (1.01.2022−31.12.2026); Principal Investigator: Margus Pooga. Financier: Estonian Research Council; Financing: 797 125 EUR. Role: Sub-project PI.
MMVBS23128R (101079349) "Boosting the One Health Research Excellence and Management Capacity of the Estonian University of Life Sciences" (1.01.2023−31.12.2025); Principal Investigator: Irja Lutsar (partner);
Financier: European Commission; Financing: 181 750 EUR.
SLTTI16143T (TK143) "Center of Excellence in Molecular Cell Engineering (TK143)" (1.01.2016−1.03.2023);
Principal Investigator: Tanel Tenson. Financier: Archimedes Foundation; Financing: 3 917 568 EUR. Role: Sub-project PI.
LLTTI20463 "Novel methods for specific modification of extracellular vesicles" (1.09.2020−31.08.2022);
Principal Investigator: Reet Kurg. Financier: HansaBioMed Life Sciences Ltd; Financing: 99 975 EUR.
PRG1169 "Design of peptide-based nanoparticles for delivery of therapeutic oligonucleotides" (1.01.2021−31.12.2021); Principal Investigator: Margus Pooga. Financier: Estonian Research Council; Financing: 257 125 EUR. Role: Sub-project PI.
MOBJD512 "The discovery of novel biomarkers for non-invasive diagnostics of melanoma" (1.01.2020−31.12.2021);
Principal Investigator: Helena Sork. Financier: Estonian Research Council; Financing: 80 884 EUR. Role: Supervisior
IUT20-27 "Interaction between virus and host: expanding knowledge for the development of biomedical tools" (1.01.2014−31.12.2019); Principal Investigator: Andres Merits. Financier: Estonian Research Council;
Financing: 2 991 466 EUR. Role: Sub-project PI.
LLTTI16290 "Testing of HPV replication inhibitors" (1.08.2016−31.03.2017);
Principal Investigator: Reet Kurg. Financier: Icosagen Cell Factory OÜ; Financing: 37 500 EUR.
SLOTI12206T (3.2.0701.12-0038) "Development of biotechnology-based food allergen surveillance methods" (1.12.2012−31.08.2015); Principal Investigator: Mart Ustav. Financier: Archimedes Foundation; Financing: 530 137 EUR.